Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - diphtheria
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Fold-Back Diabody Format for
Diphtheria
Toxin-Based Immunotoxins That Can Increase Binding and Potency
NIH inventors, in collaboration with Scott and White Memorial Hospital inventors, have developed new immunotoxins comprising a mutant
diphtheria
toxin linked to an anti-prostate specific membrane antigen (PSMA) fold-back diabody. The fold-back diabody construct has a shortened linker region between the heavy and light chains of the antibody variable...
Published: 10/28/2024
|
Inventor(s):
David Neville
Keywords(s):
A-dmDT390scfbDb591
,
Anti-prostratic
,
APPLICATION
,
Based
,
BINDING
,
CANCER
,
CB1AXX
,
CB1BXX
,
CB1CXX
,
CB1XXX
,
CBXXXX
,
CXXXXX
,
Diabody
,
DIPHTHERIA
,
Diptheria
,
Fold-back
,
FORMAT
,
Immunotoxin
,
IMMUNOTOXINS
,
INCREASE
,
particular
,
Potentcy
,
That
,
toxin
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Immunology
,
Application > Therapeutics
Activation of Recombinant
Diphtheria
Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells
This invention relates to
diphtheria
toxin fusion proteins comprising a diphtheria toxin (DT) cell-killing component and a cell-binding component such as granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin 2 (IL-2), or epidermal growth factor (EGF). Receptors for the latter three materials are present on many types of cancer cells;...
Published: 10/28/2024
|
Inventor(s):
Stephen Leppla
,
Shihui Liu
,
Manuel Osorio
,
Jennifer Avallone
Keywords(s):
CBXXXX
,
CXXXXX
,
DIPHTHERIA
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Therapeutics
Tryptophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins
Bacterial toxins such as cholera toxin and
diphtheria
toxin catalyze the ADP-ribosylation of important cellular target proteins in their human hosts, thereby, as in the case of cholera toxin, irreversibly activating adenylyl cyclase. In this reaction, the toxin transfers the ADP-ribose moiety of Nicotinamide Adenine Dinucleotide (NAD) to an acceptor...
Published: 10/28/2024
|
Inventor(s):
Joel Moss
Keywords(s):
cholera
,
DB3XXX
,
DBXXXX
,
DIPHTHERIA
,
DXXXXX
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics